Ranbaxy Australia, a subsidiary of Ranbaxy Laboratories, has introduced Atorvastatin 10mg, 20mg, 40mg and 80mg tablets after receiving approval from Therapeutic Goods Administration (TGA) in Australia.
The product is launched under the brand name Trovas in bottles and blister packs, through retail pharmacy chains. Atorvastatin, a cholesterol reducing drug, is the most prescribed statin in Australia and represents the largest patent expiry opportunity ever, in the Australian pharmaceutical market, the company said. Ranbaxy Australia managing director Alex Evans said Ranbaxy is privileged to be the first generic pany in Australia to introduce Atorvastatin under the brand name, Trovas.
